Closely associated-feasbility assessment retrospective cohort study of risk of HIP fractures associated with PPI use
Ended Awarded Last action
- Contract number
- HHSF22301008T
- Awardee
-
Harvard Pilgrim Health Care, Inc. UEI NZVVQ8GNVX65
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $189,410
Award facts
- Contract value 100% obligated
- $189,409.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Wellesley Hills, Wellesley, MA 02481, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$9,431 | |
| Original award | $198,841 |
About this award
This federal contract award is for a feasibility assessment and retrospective cohort study to examine the risk of hip fractures associated with proton pump inhibitor (PPI) use. The contract, valued at $189,409.66, was awarded to Harvard Pilgrim Health Care Inc.'s Office of Sponsored Programs Division, a non-profit healthcare organization that provides research and data analytics services to federal agencies.
The contract was awarded by the Food and Drug Administration (FDA), a civilian agency, and does not have a set-aside designation. Harvard Pilgrim has extensive experience conducting large-scale observational studies and clinical trials in partnership with federal health agencies, particularly within the Department of Health and Human Services. The organization has multiple indefinite delivery/indefinite quantity (IDIQ) contracts with the FDA and Centers for Disease Control and Prevention (CDC) to support post-market medical product safety monitoring, vaccine safety research, and other public health initiatives.
Quick answers
Who was awarded contract HHSF22301008T?
HHSF22301008T was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 12, 2012.
How much is contract HHSF22301008T worth?
The government has obligated $189,410 on HHSF22301008T.
Is contract HHSF22301008T an order under another contract?
Yes. HHSF22301008T is a delivery order under HHSF223201000009I, an indefinite delivery contract.
Was contract HHSF22301008T competed?
The extent of competition for HHSF22301008T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award